News
Patients in Scotland can't get the treatment - which is available in England - despite manufacturers giving it away for free ...
The Food and Drug Administration (FDA) has approved Imfinzi ® (durvalumab), in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by single agent Imfinzi as adjuvant ...
SHOPPING: Get set for summer with the fat-burning, drug-free supplement that helps reduce pesky cravings without causing ...
Dr. Michael Greger is famous for several books including “How Not to Die,” and for his website nutritionfacts.org. He ...
Here is a roundup of March 2025 U.S. FDA approvals across cancer subtypes, including prostate, bladder and gastrointestinal ...
Finding the best weight loss supplements for women (or anyone, really) can be like finding a needle in a haystack — except ...
“Skipping meals can lead to unintended side effects and nutritional deficiencies. While these medications suppress appetite, the body still requires consistent nourishment to maintain energy levels, ...
but unintended muscle loss associated with these drugs poses a significant health concern. Another key area for muscle preservation drugs is sarcopenia, or age-related muscle loss, which affects ...
YOKNEAM ILLIT, Israel, April 3, 2025 /PRNewswire/ -- Israeli startup ProFuse Technology, which specializes in the cultivation of muscle tissue in laboratory conditions, has launched a new technology ...
Matt Galsky, MD, delved into the recent approval of a perioperative durvalumab regimen in muscle-invasive bladder cancer.
Matt Galsky, MD, discusses the phase 3 NIAGARA trial that led to the recent FDA approval of durvalumab in muscle-invasive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results